Literature DB >> 27296563

Airway inflammation in mild cystic fibrosis.

Jonas Eckrich1, Ulrich M Zissler2, Friederike Serve1, Patricia Leutz1, Christina Smaczny3, Sabina Schmitt-Grohé1, Daniela Fussbroich1, Ralf Schubert1, Stefan Zielen1, Olaf Eickmeier4.   

Abstract

BACKGROUND: Airway infection and inflammation play major roles in the progression of cystic fibrosis (CF) lung disease. In patients with mild disease, airway inflammation is a clinically relevant and often underdiagnosed feature. Lung function, sputum cell counts, and cytokine profiles in CF with mild disease might be different in patients with and without involvement of small airway disease (SAD).
METHODS: Patients with mild CF (n=32) and 22 healthy controls were enrolled in this study. Patients with CF were assigned to two groups: (1) patients without SAD (n=19, median age 12.3years, MEF25>50% predicted), and (2) patients with SAD (n=13 median age, 13.2years, MEF25<50% predicted). Lung function parameters were measured, cells in induced sputum were counted, and cytokines/chemokines (IL-1β, IL-6, IL-8, TNF-α) were analyzed by real-time quantitative PCR (qRT-PCR) and cytometric bead array (CBA).
RESULTS: Patients with CF had significant elevated levels of pro-inflammatory genes in qRT-PCR and secreted gene products in CBA compared to controls. Patients with CF and SAD had significantly increased trapped air (RV/TLC) and pronounced airway inflammation compared to controls as indicated by elevated levels of sputum biomarkers like total cells, neutrophils, and IL6.
CONCLUSIONS: Our study demonstrated that patients with CF with mild disease defined by lung function might be further endotyped according to their involvement of SAD. In patients with CF and SAD, airway neutrophilic inflammation is more pronounced and is in part distinct from that seen in patients without SAD.
Copyright © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airway inflammation; Cystic fibrosis; Gene expression; Induced sputum; Pro-inflammatory biomarkers; Small airway disease

Mesh:

Substances:

Year:  2016        PMID: 27296563     DOI: 10.1016/j.jcf.2016.05.016

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  9 in total

Review 1.  Advanced Role of Neutrophils in Common Respiratory Diseases.

Authors:  Jinping Liu; Zhiqiang Pang; Guoqiang Wang; Xuewa Guan; Keyong Fang; Ziyan Wang; Fang Wang
Journal:  J Immunol Res       Date:  2017-05-15       Impact factor: 4.818

2.  Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis.

Authors:  Gisela Hovold; Victoria Palmcrantz; Fredrik Kahn; Arne Egesten; Lisa I Påhlman
Journal:  BMC Pulm Med       Date:  2018-06-20       Impact factor: 3.317

Review 3.  Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.

Authors:  Meraj A Khan; Zubair Sabz Ali; Neil Sweezey; Hartmut Grasemann; Nades Palaniyar
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

4.  Longitudinal analysis of sinus microbiota post endoscopic surgery in patients with cystic fibrosis and chronic rhinosinusitis: a pilot study.

Authors:  Brett Wagner Mackenzie; Camila Dassi; Anitha Vivekanandan; Melissa Zoing; Richard G Douglas; Kristi Biswas
Journal:  Respir Res       Date:  2021-04-13

5.  Novel therapeutic approaches for the management of cystic fibrosis.

Authors:  Ryan Jaques; Arslan Shakeel; Cameron Hoyle
Journal:  Multidiscip Respir Med       Date:  2020-11-26

Review 6.  The Gram-Negative Bacilli Isolated from Caves-Sphingomonas paucimobilis and Hafnia alvei and a Review of Their Involvement in Human Infections.

Authors:  Mihaela Ileana Ionescu; Dan Ștefan Neagoe; Alexandra Marioara Crăciun; Oana Teodora Moldovan
Journal:  Int J Environ Res Public Health       Date:  2022-02-17       Impact factor: 3.390

7.  The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients.

Authors:  Caroline Morin; André M Cantin; Félix-Antoine Vézina; Samuel Fortin
Journal:  Mar Drugs       Date:  2018-05-26       Impact factor: 5.118

8.  Enhanced inflammasome activation and reduced sphingosine-1 phosphate S1P signalling in a respiratory mucoobstructive disease model.

Authors:  Hai B Tran; Matthew G Macowan; Adrian Abdo; Martin Donnelley; David Parsons; Sandra Hodge
Journal:  J Inflamm (Lond)       Date:  2020-04-21       Impact factor: 4.981

9.  Calprotectin as a New Sensitive Marker of Neutrophilic Inflammation in Patients with Bronchiolitis Obliterans.

Authors:  S P Jerkic; F Michel; H Donath; E Herrmann; R Schubert; M Rosewich; S Zielen
Journal:  Mediators Inflamm       Date:  2020-05-01       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.